610 related articles for article (PubMed ID: 25499079)
1. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
3. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
4. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
5. Biology and clinical applications of pancreatic cancer stem cells.
Abel EV; Simeone DM
Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
7. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.
Takao S; Ding Q; Matsubara S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):614-20. PubMed ID: 22878838
[TBL] [Abstract][Full Text] [Related]
10. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.
Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J
Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
Leal JA; Lleonart ME
Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs regulate tumor cell plasticity.
Liu B; Sun L; Song E
Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
15. microRNAs and Prostate Cancer.
Josson S; Chung LW; Gururajan M
Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
[TBL] [Abstract][Full Text] [Related]
16. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
Wang S; Huang S; Sun YL
Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
[TBL] [Abstract][Full Text] [Related]
19. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
[TBL] [Abstract][Full Text] [Related]
20. Pathobiology of pancreatic cancer: implications on therapy.
Regel I; Hausmann S; Benitz S; Esposito I; Kleeff J
Expert Rev Anticancer Ther; 2016; 16(2):219-27. PubMed ID: 26652651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]